PEAK BIO(PKBO) - 2023 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR 7 Table of Contents Page PART I. FINANCIAL INFORMATION | Item 1. | Condensed Consolidated Financial Statements (Unaudited) | 3 | | --- | --- | --- | | | Condensed Consolidated Balance Sheets | 3 | | | Condensed Consolidated Statements of Operations and Comprehensive Loss | 4 | | | C ...